News

Moderna's new COVID-19 vaccine mNexspike approved by FDA, but there's a limit on who can use it
The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna ...
FDA approves Moderna’s new lower-dose COVID-19 vaccine
The Food and Drug administration has approved a new COVID-19 vaccine made by Moderna but with limits on who can use it.
US FDA approves Moderna's next-generation COVID vaccine for adults 65 or older
The U.S. Food and Drug Administration has approved Moderna's next-generation COVID-19 vaccine for everyone aged 65 and above, ...
U.S. Cancels Contract With Moderna to Develop Bird Flu Vaccine
Health Secretary Robert F. Kennedy Jr. has repeatedly questioned the safety of mRNA technology, which is used in the ...
US cancels more than $700 million funding for Moderna bird flu vaccine
The Trump administration has canceled a contract awarded to Moderna for the late-stage development of its bird flu vaccine ...
U.S. Ends $600M Moderna Bird Flu Vaccine Contract
THURSDAY, May 29, 2025 (HealthDay News) — The U.S. government has canceled a $600 million contract with Moderna to develop a ...
Explore more
Moderna Receives U.S. FDA Approval for COVID-19 Vaccine mNEXSPIKE
NEXSPIKE becomes Moderna’s third FDA-approved product CAMBRIDGE, MA / ACCESS Newswire / May 31, 2025 / Moderna, Inc.
Trump Admin Cancels $766 Million Moderna Contract To Fight Pandemic Flu
The Trump administration has canceled $766 million awarded to drugmaker Moderna Inc. to develop a vaccine against potential ...
Daily Wrap on MSN2h
FDA approves Moderna's new vaccine for the most vulnerable
The US Food and Drug Administration (FDA) has approved Moderna's new mNEXSPIKE vaccine, designed for the elderly and those ...
Moderna Wins Narrower US Approval for New Covid Vaccine
Moderna Inc. gained US approval for a new Covid vaccine for a narrower group of people, in the latest sign that regulators ...